Sicart Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$383K |
| 2 |
Pinduoduo
PDD
|
+$380K |
| 3 |
XYZ
Block Inc
XYZ
|
+$294K |
| 4 |
Roblox
RBLX
|
+$188K |
| 5 |
DNA X Inc
SONM
|
+$104K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$4.04M |
| 2 |
Kraft Heinz
KHC
|
+$2.62M |
| 3 |
Albemarle
ALB
|
+$2.5M |
| 4 |
Nutrien
NTR
|
+$1.85M |
| 5 |
Gilead Sciences
GILD
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 17.34% |
| 2 | Healthcare | 16.5% |
| 3 | Communication Services | 13.55% |
| 4 | Materials | 11.25% |
| 5 | Technology | 9.02% |
Similar funds
Sicart Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Sicart Associates held 78 positions worth $257M, down 9.3% from $284M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Sicart Associates withdrew a net $42.5M in Q1 2023, closing 9 positions and reducing 48 holdings. Its most notable exit was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $1.78M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Sicart Associates opened a new position in Block Inc worth $270K.
- Sicart Associates's largest Q1 2023 buy was Block Inc: 3,930 shares worth $270K.
- Sicart Associates added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $383K increase.
- Sicart Associates's biggest Q1 2023 reduction was SPDR Gold Trust, cutting an estimated $4.04M.
- Sicart Associates fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2023, selling an estimated $1.78M.
- Sicart Associates's ten largest holdings make up 46% of its $257M portfolio in Q1 2023.
- Sicart Associates opened 4 new positions and closed 9 in Q1 2023.
- Sicart Associates's portfolio value fell 9.3% quarter-over-quarter to $257M.
Based on Sicart Associates's 13F filing for Q1 2023, filed 9 May 2023.